日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting PLK1-CBX8-GPX4 axis overcomes BRAF/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis.

通过铁死亡靶向 PLK1-CBX8-GPX4 轴可克服 BRAFV600E 结直肠癌中的 BRAF/EGFR 抑制剂耐药性

Zhao Zhan, He Jiashuai, Qiu Shenghui, Wang Lu, Huangfu Shuchen, Hu Yangzhi, Wu Qing, Yang Yabing, Li Xiaobo, Huang Maohua, Liu Shijin, Guan Hanyang, Chen Zuyang, Zhang Xiangwei, Zhang Yiran, Ding Hui, Zhao Xiaoxu, Xiao Guandi, Pan Yunlong, Liu Tongzheng, Wu Yanping, Pan Jinghua

Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis

伽玛刀立体定向放射治疗联合替雷利珠单抗作为pMMR/MSS/MSI-L转移性结直肠癌的后线治疗:一项II期临床试验分析

Zhang, Yiran; Guan, Hanyang; Liu, Shijin; Li, Haoquan; Bian, Zili; He, Jiashuai; Zhao, Zhan; Qiu, Shenghui; Mo, Tianmu; Zhang, Xiangwei; Chen, Zuyang; Ding, Hui; Zhao, Xiaoxu; Wang, Liang; Pan, Yunlong; Pan, Jinghua

Characterization of a novel cell line established from mice gastrointestinal stromal model by chemical induction.

通过化学诱导从小鼠胃肠道基质模型中建立的新型细胞系的特性分析

Zhao Zhan, Qiu Shenghui, Zhang Xiangwei, Liu Shijin, Wang Lu, Guan Hanyang, He Jiashuai, Hu Yangzhi, Li Xiaobo, Luo Simin, Chen Zuyang, Mo Tianmu, Zhang Yiran, Zhao Xiaoxu, Pan Yunlong, Ding Hui, Cao Jie, Pan Jinghua

Tumor neoantigens: Novel strategies for application of cancer immunotherapy

肿瘤新抗原:癌症免疫治疗应用的新策略

Guan, Hanyang; Wu, Yue; Li, L U; Yang, Yabing; Qiu, Shenghui; Zhao, Zhan; Chu, Xiaodong; He, Jiashuai; Chen, Zuyang; Zhang, Yiran; Ding, Hui; Pan, Jinghua; Pan, Yunlong